Prof. Yongping Song 宋永平
Chief Physician, Professor
Department of Hematology, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of leukemia, severe aplastic anemia, lymphoma, and multiple myeloma.
Dr. Song graduated from Henan Medical University in 1984. As Director of the Henan Institute of Hematology, Dr. Song performed China’s first umbilical cord blood stem cell transplant for acute leukemia in 1998. Dr. Song has published 86 papers, including 11 indexed by SCI, and holds over 20 national and provincial research grants.
Professional roles
- Standing Committee Member, Chinese Medical Association
- National Committee Member, Chinese Society of Clinical Oncology (CSCO)
- Standing Committee Member, Hematology Branch of Chinese Medical Doctor Association
- Member, Lymphoma Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Song Yongping). Papers usually list the name as Yongping Song or Song Y.
Selected publications
216 papers on PubMed matched by name and affiliation; 55 as first or senior author since 2016. Most recent first- or senior-author papers:
- Chin Med J (Engl), 2025 (senior author): Decoding the immune microenvironment of secondary chronic myelomonocytic leukemia due to diffuse large B-cell lymphoma with CD19 CAR-T failure by single-cell RNA-sequencing. PubMed 40625291
- Genes Dis, 2024 (senior author): Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia. PubMed 38947742
- Chin Med J (Engl), 2024 (senior author): Chimeric antigen receptor-immune cells against solid tumors: Structures, mechanisms, recent advances, and future developments. PubMed 37640679
- Chin Med J (Engl), 2024 (senior author): Immune cells in the B-cell lymphoma microenvironment: From basic research to clinical applications. PubMed 38269619
- Leuk Res, 2023 (senior author): A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes. PubMed 37844405
- Exp Hematol Oncol, 2023 (senior author): Single VHH-directed BCMA CAR-NK cells for multiple myeloma. PubMed 38012722
- Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2023 (senior author): [Efficacy of Tyrosine Kinase Inhibitor Combined with Decitabine, Homoharringtonine, Interferon in the Maintenance Therapy of Blast Phase Chronic Myeloid Leukemia]. PubMed 37356921
- Arch Med Res, 2023 (senior author): Hsa_circ_0111738 Inhibits Tumor Progression and Angiogenesis in Multiple Myeloma by Sponging miR-1233-3p to Regulate HIF-1 Signaling Pathway. PubMed 37211508
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion